COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 1350: Articles 13491-13500  | Next

Antibody response to SARS-CoV-2 infection and BNT162b2 vaccine in Israel
Shapira, G., Abu Hamad, R., Weiner, C., Rainy, N., Sorek-Abramovich, R., Benveniste-Levkovitz, P., Chaim, A. B., Shomron, N.
10.1101/2021.07.07.21259499 — Posted: 2021-07-08
COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United States
Moghadas, S., Sah, P., Fitzpatrick, M. C., Shoukat, A., Pandey, A., Vilches, T. N., Singer, B. H., Schneider, E. C., Galvani, A. P.
10.1101/2021.07.07.21260156 — Posted: 2021-07-08
Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis
Harwood, R., Yan, H., Talawila Da Camara, N., Smith, C., Ward, J., Tudur-Smith, C., Linney, M., Clark, M., Whittaker, E., Saatci, D., Davis, P. J., Luyt, K., Draper, E. S., Kenny, S., Fraser, L. K., Viner, R. M.
10.1101/2021.06.30.21259763 — Posted: 2021-07-08 Discussion: Onsite
COVID-19 Due to Wild-Type SARS-CoV-2 More Prevalent in Adolescents and Youth than in Older Adults Based on 19 US States in Fall 2020 Prior to Vaccine Availability
Rumain, B. T., Schneiderman, M., Geliebter, A.
10.1101/2021.07.06.21260112 — Posted: 2021-07-08
SARS-CoV-2 Neurotropism and Single Cell Responses in Brain Organoids Containing Innately Developing Microglia
Samudyata, , Oliveira, A. O., Malwade, S., de Sousa, N. R., Goparaju, S. K., Orhan, F., Steponaviciute, L., Sheridan, S. D., Perlis, R. H., Rothfuchs, A. G., Sellgren-Majkowitz, C.
10.1101/2021.07.07.451463 — Posted: 2021-07-08 Discussion: Offsite
Multivalent designed proteins protect against SARS-CoV-2 variants of concern
Hunt, A. C., Case, J. B., Park, Y.-J., Cao, L., Wu, K., Walls, A. C., Liu, Z., Bowen, J. E., Yeh, H.-W., Saini, S., Helms, L., Zhao, Y. T., Hsiang, T.-Y., Starr, T. N., Goreshnik, I., Kozodoy, L., Carter, L., Ravichandran, R., Green, L. B., Matochko, W. L., Thomson, C. A., Vogeli, B., Kruger-Gericke, A., VanBlargan, L. A., Chen, R. E., Ying, B., Bailey, A. L., Kafai, N. M., Boyken, S., Ljubetic, A., Edman, N., Ueda, G., Chow, C., Addetia, A., Panpradist, N., Gale, M., Freedman, B., Lutz, B., Bloom, J. D., Ruohola-Baker, H., Whelan, S. P. J., Stewart, L., Diamond, M. S., Veesler, D., Jewett, M. C., Baker, D.
10.1101/2021.07.07.451375 — Posted: 2021-07-07
CAT, AGTR2, L-SIGN and DC-SIGN are potential receptors for the entry of SARS-CoV-2 into human cells
Guo, D., Guo, R., Li, Z., Zhang, Y., Zheng, W., Huang, X., Aziz, T., Zhang, Y., Liu, L.
10.1101/2021.07.07.451411 — Posted: 2021-07-07
Receptor-binding domain recombinant protein RBD219-N1C1 on alum-CpG induces broad protection against SARS-CoV-2 variants of concern
Pollet, J., Strych, U., Chen, W.-H., Versteeg, L., Keegan, B., Zhan, B., Wei, J., Liu, Z., Lee, J., Kundu, R., Adhikari, R., Poveda, C., Villar, M. J., Lopez, B., Gillespie, P. M., Ronca, S., Kimata, J. T., Reers, M., Paradkar, V., Hotez, P., Bottazzi, M. E.
10.1101/2021.07.06.451353 — Posted: 2021-07-07
Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
van Doremalen, N., Fischer, R., Schulz, J., Holbrook, M., Smith, B., Lovaglio, J., Petsch, B., Munster, V.
10.1101/2021.07.07.451505 — Posted: 2021-07-07
Defining the Immune Responses for SARS-CoV-2-Human Macrophage Interactions
Mostafa, M., Yeapuri, P., Machhi, J., Olson, K., Shahjin, F., Zhou, Y., Jingjing, L., Pandey, K., Acharya, A., Byrareddy, S., Mosley, L., Gendelman, H.
10.1101/2021.07.07.449660 — Posted: 2021-07-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).